Balance Sheet

Assets

+65%

+89%

10Y

Currency: USD

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	34	61	49	179	183	142	219	334	396	171	311	420	654	718	930	818	714	1 179	1 183	863	769	1 144	3 045	2 938
Cash Equivalents	34	61	49	179	183	142	219	334	396	171	311	420	654	718	930	818	714	1 179	1 183	863	769	1 144	3 045	2 938
Short-Term Investments	0	0	0	0	0	49	8	0	0	279	211	517	785	506	341	519	242	338	219	604	446	501	931	1 288
Total Receivables	108	119	119	119	127	145	205	272	303	321	348	328	325	372	415	479	537	599	603	665	699	837	727	912
Accounts Receivables	88	98	104	101	112	116	186	249	277	284	321	303	288	315	415	439	457	544	515	582	643	775	609	660
Other Receivables	20	21	15	17	16	30	18	23	25	37	26	26	37	56	0	41	80	56	88	83	56	62	118	253
Inventory	112	121	128	132	142	153	152	166	204	261	281	309	297	340	397	555	607	641	802	727	876	1 168	1 087	1 126
Other Current Assets	66	60	72	86	80	97	109	117	130	136	142	152	171	112	158	178	186	227	283	322	306	386	495	474
Total Current Assets	320	360	368	514	532	586	692	889	1 033	1 169	1 292	1 726	2 231	2 048	2 240	2 549	2 287	2 984	3 091	3 181	3 096	4 036	6 285	6 739
PP&E Net	209	210	202	202	213	228	230	252	270	304	373	422	443	483	580	680	868	1 140	1 489	1 639	1 725	1 843	1 784	1 915
PP&E Gross	209	210	202	202	213	228	230	252	270	304	373	422	443	483	0	0	868	1 140	1 489	1 639	1 725	1 843	1 784	1 915
Accumulated Depreciation	196	214	237	235	242	242	241	253	273	300	321	343	365	372	0	0	455	512	599	655	750	857	795	850
Intangible Assets	65	81	153	138	116	123	97	87	67	67	67	34	23	205	205	468	343	337	331	324	285	428	1 177	1 128
Goodwill	334	338	338	338	338	350	316	315	315	350	385	385	376	628	626	1 127	1 112	1 168	1 173	1 168	1 164	1 254	1 777	1 769
Note Receivable	0	0	0	0	0	0	0	0	0	25	10	7	6	0	0	0	0	0	0	0	0	0	0	489
Long-Term Investments	24	35	21	11	20	34	15	22	25	22	21	22	241	380	532	567	506	586	802	1 834	1 239	584	308	279
Other Long-Term Assets	53	77	33	27	28	28	51	50	58	45	74	114	203	312	327	276	208	274	351	358	783	1 218	1 725	1 380
Other Assets	334	338	338	338	338	350	316	315	315	350	385	385	376	628	626	1 127	1 112	1 168	1 173	1 168	1 164	1 254	1 777	1 769
Total Assets	1 004 N/A	1 101 +10%	1 113 +1%	1 229 +10%	1 247 +1%	1 350 +8%	1 400 +4%	1 616 +15%	1 767 +9%	1 981 +12%	2 222 +12%	2 710 +22%	3 523 +30%	4 056 +15%	4 510 +11%	5 666 +26%	5 324 -6%	6 488 +22%	7 237 +12%	8 503 +17%	8 293 -2%	9 363 +13%	13 055 +39%	13 697 +5%
Liabilities
Accounts Payable	70	67	62	61	49	64	66	51	48	85	75	332	56	69	97	117	134	180	197	205	202	1 372	251	228
Accrued Liabilities	108	117	113	108	140	162	187	204	206	220	263	0	340	378	418	516	510	643	579	714	668	820	857	1 004
Short-Term Debt	0	0	0	0	0	150	0	0	42	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	598	0	0	0	0	0	0	0	0
Other Current Liabilities	0	0	20	25	37	5	6	36	43	31	10	13	31	29	17	189	232	79	119	114	153	174	398	583
Total Current Liabilities	177	184	195	194	226	380	259	291	338	335	347	346	426	476	533	1 420	877	902	894	1 032	1 022	1 195	1 505	1 814
Long-Term Debt	246	256	267	316	236	62	176	90	0	150	189	593	598	597	822	438	594	594	595	596	596	597	598	598
Deferred Income Tax	0	0	0	0	0	0	0	0	0	0	0	126	195	195	0	0	125	172	214	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	69	65	0
Other Liabilities	42	26	22	29	35	73	87	77	121	157	206	100	113	285	536	852	588	671	960	1 039	867	851	890	948
Total Liabilities	465 N/A	466 +0%	485 +4%	539 +11%	497 -8%	515 +3%	521 +1%	458 -12%	459 +0%	643 +40%	742 +15%	1 166 +57%	1 332 +14%	1 553 +17%	1 891 +22%	2 710 +43%	2 183 -19%	2 340 +7%	2 663 +14%	2 667 +0%	2 486 -7%	2 713 +9%	3 057 +13%	3 360 +10%
Equity
Common Stock	60	63	64	66	67	69	74	76	117	120	124	126	129	239	243	212	215	218	636	642	646	651	655	659
Retained Earnings	143	222	224	303	434	549	677	906	1 124	1 361	1 654	2 031	2 842	3 337	3 906	1 962	2 695	3 742	4 565	6 068	7 590	8 992	13 167	14 241
Additional Paid In Capital	412	463	501	537	604	681	940	1 056	211	301	489	671	878	947	1 168	1 167	1 384	1 623	1 438	1 700	1 969	2 274	2 613	2 768
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	1	0	0	2	0	5	5	2	9	7	66	25	4	1
Treasury Stock	32	81	140	194	339	470	777	872	102	406	750	1 256	1 557	1 837	2 499	252	1 015	1 279	1 904	2 417	4 144	5 025	6 192	7 092
Other Equity	45	32	21	22	16	8	35	8	42	38	39	28	101	181	198	128	134	158	170	151	189	218	241	238
Total Equity	539 N/A	635 +18%	628 -1%	690 +10%	749 +9%	835 +11%	879 +5%	1 158 +32%	1 308 +13%	1 338 +2%	1 479 +11%	1 544 +4%	2 191 +42%	2 503 +14%	2 619 +5%	2 956 +13%	3 140 +6%	4 148 +32%	4 574 +10%	5 836 +28%	5 807 -1%	6 650 +15%	9 998 +50%	10 338 +3%
Total Liabilities & Equity	1 004 N/A	1 101 +10%	1 113 +1%	1 229 +10%	1 247 +1%	1 350 +8%	1 400 +4%	1 616 +15%	1 767 +9%	1 981 +12%	2 222 +12%	2 710 +22%	3 523 +30%	4 056 +15%	4 510 +11%	5 666 +26%	5 324 -6%	6 488 +22%	7 237 +12%	8 503 +17%	8 293 -2%	9 363 +13%	13 055 +39%	13 697 +5%
Shares Outstanding
Common Shares Outstanding	706	714	713	714	692	679	671	682	690	685	686	656	323	646	635	629	623	627	624	624	608	601	589	581

Income Statement Balance Sheet Cash Flow Statement

Edwards Lifesciences Corp
NYSE:EW

Balance Sheet

Balance Sheet Decomposition
Edwards Lifesciences Corp

Balance Sheet
Edwards Lifesciences Corp

See Also

Company

Help

Tools

Stocks

Edwards Lifesciences Corp NYSE:EW

Balance Sheet

Balance Sheet Decomposition Edwards Lifesciences Corp

Balance Sheet Edwards Lifesciences Corp

See Also

Company

Help

Tools

Stocks

Edwards Lifesciences Corp
NYSE:EW

Balance Sheet Decomposition
Edwards Lifesciences Corp

Balance Sheet
Edwards Lifesciences Corp